According to the INFACT Canada mailing list
Common ingredient in infant formula linked to diarrhea, severe dehydration, and seizures in babies, according to complaints submitted to the FDA
A shocking report has been released on the adverse health effects of fatty acids found in infant formulas. On Friday the Cornucopia Institute, a U.S.-based corporate watchdog group, presented their findings on the fatty acids DHA and ARA, which are now commonly added to formula.
The report is based on a Freedom of Information Act request that the Cornucopia Institute filed with the Food and Drug Administration, the result of which was the uncovering of 98 reports filed by parents and physicians detailing incidences when babies had reacted adversly to formula containing DHA/ARA. The reported incidences range from cases of vomitting and diarrhea that stopped when babies switched to non-DHA/ARA formula to babies being treated in intensive care units for severe dehydration and seizures.
The FDA has never been convinced of the safety of DHA/ARA additives, according to the report. In its initial analysis of the additives, the FDA stated it had reached no determination on their safety status. The administration also noted that some studies had reported unexpected deaths among infants who had been fed with DHA/ARA formula. Despite its reservations, inexplicably the FDA did not withhold approval for the additives.
INFACT Canada has long questioned the use of DHA and ARA (also marketed as omega-3 and omega-6 fatty acids) in infant formula. All major formula companies have added the fatty acids to their products in recent years, claiming that they aid in brain and eye development. However most test results have found the additives have negligable effects on infant development. But because DHA and ARA are found naturally in breastmilk, formula companies market DHA/ARA formula as “closer to breastmilk.”
Martek Biosciences Corporation, the company which supplies almost all formula companies with DHA/ARA, has admitted that the purpose of the additives is not to encourage healthy development, but to be used as a marketing tool. In its promotional material to encourage investment, Martek has stated:
“Infant formula is currently a commodity market, with all products being almost identical and marketers competing intensely to differentiate their product. Even if [DHA/ARA] has no benefit, we think it would be widely incorporated into formulas, as a marketing tool and to allow companies to promote their formula as “closest to human milk.”
While DHA and ARA are found naturally in breastmilk, the idea that Martek’s manufactured acids make formula closer to breastmilk is ridiculous. Martek produces DHA and ARA from fermented algae and fungus, and uses hexane (a neurotoxin) in the manufacturing process. Simply adding these synthetic substances to formula cannot make artificial baby milk behave like breastmilk, which is a complex, living substance that provides babies with the best possible nutrition and immunological protection.
Regular infant formula puts babies’ health at risk, but now infants are being harmed for the sake of a marketing tool. This is an egregious case of formula companies putting profit margins above infant health. In light of this report, it is imperative that all parents be made aware of the potential risks of feeding their babies formula with DHA/ARA. The products should be pulled from the market until their safety can be properly assessed by independent investigations.
Babies should not have to get sick just because companies want to raise their sales figures.
For the more information on the Cornucopia report, please see: http://foodconsumer.org/7777/8888/C_hildren_amp_W_omen_33/012510002008_Lab-made_imitation_breast_milk_puts_infants_at_risk_study_shows.shtml
For the full report, see: http://cornucopia.org/DHA/DHA_FullReport.pdf
